25
Jun 2026
The British Heart Foundation is celebrating three incredible young women who donated their old hearts to science after having heart transplant surgery.
25
Jun 2026
At a time when energy security and affordability have risen to the top of the development agenda, 655 million people globally still lack access to electricity, and two billion use polluting fuels and technologies for cooking putting their health and well-being at risk.
25
Jun 2026
New research, published in The Journal of Immunology, identified biomarkers of a distinct immune profile that could be used to identify patients at risk for chronic critical illness (CCI) upon admittance to the intensive-care unit (ICU) after traumatic injury.
25
Jun 2026
Early detection and timely treatment of heart failure in pregnant or postpartum women are crucial to prevent serious complications, such as irregular heartbeat, stroke and death, according to a new American Heart Association scientific statement, "Heart Failure Occurring in the Perinatal Period."
25
Jun 2026
OMED Health ("OMED"), part of Owlstone Medical ("Owlstone"), the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, and Welbeck Health Partners ("Welbeck"), one of the UK's largest specialist outpatient healthcare providers, today announced that Welbeck has adopted OMED Health's home-based Small Intestinal Bacterial Overgrowth (SIBO) breath-testing pathway. The roll out across Welbeck's network follows a three-month evaluation where the pathway was assessed for performance and impact on standard of care.
25
Jun 2026
Patients with chronic pain do not have access to specialized rehabilitation on equal terms. Education, age, sex, and region of birth appear to play a role, particularly in combination, according to a Sweden-based study from the University of Gothenburg.
25
Jun 2026
NVIDIA today announced NVIDIA BioNeMo Agent Toolkit, which provides domain-specific tools and skills for the agentic life sciences era.
25
Jun 2026
Researchers found that maternal plasma cell-free DNA methylation patterns in late pregnancy were associated with later autism diagnosis and maternal obesity in a high-likelihood ASD cohort. The findings suggest cfDNA may offer a minimally invasive way to study prenatal epigenetic changes linked to neurodevelopmental risk, but larger validation studies are needed.
25
Jun 2026
Tecan, a global provider of laboratory automation and solutions, today announced the integration of Agentic AI capabilities into its lab analytics platform Introspect, leveraging NVIDIA BioNeMo Agent Toolkit.
25
Jun 2026
A review in Cardiology in Review highlights GPR75, a receptor for 20-HETE, as a promising therapeutic target for obesity and metabolic syndrome. Evidence from genetic studies, cell experiments, and mouse models suggests that blocking this pathway could influence weight gain, insulin resistance, hypertension, inflammation, and vascular dysfunction.
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more
